Goldman Sachs Group Inc Vir Biotechnology, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 832,683 shares of VIR stock, worth $5.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
832,683
Previous 782,799 6.37%
Holding current value
$5.93 Million
Previous $6.97 Million 10.48%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.26 - $10.7 $362,157 - $533,758
49,884 Added 6.37%
832,683 $6.24 Million
Q2 2024

Aug 13, 2024
SELL
$7.63 - $12.66 $912,113 - $1.51 Million
-119,543 Reduced 13.25%
782,799 $6.97 Million
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $2.79 Million - $3.86 Million
324,585 Added 56.18%
902,342 $9.14 Million
Q4 2023

Feb 13, 2024
BUY
$7.76 - $10.29 $1.36 Million - $1.81 Million
175,543 Added 43.64%
577,757 $5.81 Million
Q3 2023

May 14, 2024
SELL
$9.14 - $24.62 $1.6 Million - $4.32 Million
-175,543 Reduced 30.38%
402,214 $3.77 Million
Q3 2023

Nov 14, 2023
SELL
$9.14 - $24.62 $783,188 - $2.11 Million
-85,688 Reduced 17.56%
402,214 $3.77 Million
Q2 2023

May 14, 2024
BUY
$23.2 - $27.29 $2.14 Million - $2.51 Million
92,095 Added 23.27%
487,902 $12 Million
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $2.14 Million - $2.51 Million
92,095 Added 23.27%
487,902 $12 Million
Q1 2023

May 14, 2024
SELL
$22.26 - $30.85 $4.93 Million - $6.83 Million
-221,350 Reduced 35.87%
395,807 $9.21 Million
Q1 2023

May 11, 2023
SELL
$22.26 - $30.85 $4.93 Million - $6.83 Million
-221,350 Reduced 35.87%
395,807 $9.21 Million
Q4 2022

May 14, 2024
SELL
$19.96 - $28.22 $1.43 Million - $2.02 Million
-71,625 Reduced 10.4%
617,157 $15.6 Million
Q4 2022

Feb 13, 2023
SELL
$19.96 - $28.22 $1.43 Million - $2.02 Million
-71,625 Reduced 10.4%
617,157 $15.6 Million
Q3 2022

May 14, 2024
BUY
$18.26 - $31.1 $4.01 Million - $6.83 Million
219,702 Added 46.84%
688,782 $13.3 Million
Q3 2022

Nov 10, 2022
BUY
$18.26 - $31.1 $4.01 Million - $6.83 Million
219,702 Added 46.84%
688,782 $13.3 Million
Q2 2022

May 14, 2024
SELL
$19.08 - $26.7 $2.07 Million - $2.9 Million
-108,677 Reduced 18.81%
469,080 $11.9 Million
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $2.84 Million - $3.97 Million
-148,670 Reduced 24.07%
469,080 $11.9 Million
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $1.28 Million - $2.42 Million
60,368 Added 10.83%
617,750 $15.9 Million
Q4 2021

Feb 14, 2022
SELL
$30.97 - $54.03 $1.82 Million - $3.17 Million
-58,713 Reduced 9.53%
557,382 $23.3 Million
Q3 2021

Nov 10, 2021
BUY
$34.9 - $54.54 $21.5 Million - $33.6 Million
616,095 New
616,095 $26.8 Million

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $944M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email